Home > Riviste > International Angiology > Fascicoli precedenti > International Angiology 2006 December;25(4) > International Angiology 2006 December;25(4):370-7

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

INTERNATIONAL ANGIOLOGY

Rivista di Angiologia


Official Journal of the International Union of Angiology, the International Union of Phlebology and the Central European Vascular Forum
Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,899


eTOC

 

Original articles  


International Angiology 2006 December;25(4):370-7

lingua: Inglese

Are there differences of inflammatory bio-markers between diabetic and non-diabetic patients with critical limb ischemia?

Bertz L. 1, Barani J. 1, Gottsäter A. 1, Nilsson P. M. 2, Mattiasson I. 1, Lindblad B. 1

1 Department of Vascular Diseases Malmö-Lund, Lund University, Malmö University Hospital, Malmö, Sweden
2 Department of Medicine, Lund University, Malmö University Hospital, Malmö, Sweden


PDF  


Aim. This observational study was undertaken in order to analyse whether any differences could be detected between diabetic and non-diabetic patients with critical limb ischemia (CLI) concerning the inflammatory response.
Methods. A total number of 259 consecutive patients with CLI were treated between October 2001 and January 2003.
Results. Among the 259 patients, 135 (52%) had diabetes, previously known in 123, and detected during hospitalization in 12. The diabetic patients more often showed gangrene (P<0.05) and infra-inguinal atherosclerosis (84% vs 67%, P=0.001). The patients with diabetes showed a better lipid profile (total cholesterol 4.6 vs 5 mmol/L, P=0.006 and lower LDL-cholesterol (2.7 vs 3.1 mmol/L, P=0.010) despite the same frequency of statin treatment. They showed a higher creatinine (149 vs 117 µmol/L, P=0.0003) than the non-diabetic patients. Of the inflammatory markers, C-reactive protein (CRP) was equally elevated in both groups. Tumor necrosis factor-a (TNF-a) was increased among the diabetic patients (2.6 vs 1.8 pg/mL, P<0.05), and this difference was most evident in those with gangrene. Neopterin was also higher among the diabetic patients (31 vs 21 mmol/L, P<0.01), but CD40L was not different between groups.
Conclusions. Diabetes mellitus was very common in CLI patients, and more often combined with renal impairment and infra-inguinal atherosclerosis. The inflammatory markers TNF-α and neopterin were elevated in patients with diabetes as compared to non-diabetic patients, but this difference cannot explain why CLI is 10 times more frequent in diabetic patients.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail